Literature DB >> 20637610

Synthesis of novel oxime-containing pyrazole derivatives and discovery of regulators for apoptosis and autophagy in A549 lung cancer cells.

Liang-Wen Zheng1, Ying Li, Di Ge, Bao-Xiang Zhao, Ying-Rui Liu, Hong-Shui Lv, Jun Ding, Jun-Ying Miao.   

Abstract

A series of novel oxime-containing pyrazole derivatives were synthesized by the reaction of ethyl 3-phenyl-1H-pyrazole-5-carboxylate derivatives and 2-bromo-1-phenylethanone followed by the reaction with hydroxylamine hydrochloride. The structures were determined by IR, (1)H NMR, HRMS, and X-ray analysis. A dose- and time-dependent inhibition of proliferation was observed in A549 lung cancer cell after compound treatment. Inhibition of growth was mainly attributed to the autophagy induction. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20637610     DOI: 10.1016/j.bmcl.2010.06.121

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

Review 1.  Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review.

Authors:  Khalid Karrouchi; Smaail Radi; Youssef Ramli; Jamal Taoufik; Yahia N Mabkhot; Faiz A Al-Aizari; M'hammed Ansar
Journal:  Molecules       Date:  2018-01-12       Impact factor: 4.411

2.  Regioselective synthesis and biological studies of novel 1-aryl-3, 5-bis (het) aryl pyrazole derivatives as potential antiproliferative agents.

Authors:  Hanumappa Ananda; Kothanahally S Sharath Kumar; Mayilaadumveettil Nishana; Mahesh Hegde; Mrinal Srivastava; Raghava Byregowda; Bibha Choudhary; Sathees C Raghavan; Kanchugarakoppal S Rangappa
Journal:  Mol Cell Biochem       Date:  2016-11-24       Impact factor: 3.396

3.  Ethyl 3-(4-chloro-phen-yl)-1-(2-oxo-2-phenyl-eth-yl)-1H-pyrazole-5-carboxyl-ate.

Authors:  Liang-Wen Zheng; Yin-Rui Liu; Bao-Xiang Zhao
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-07-06

Review 4.  Curcumin: updated molecular mechanisms and intervention targets in human lung cancer.

Authors:  Ming-Xiang Ye; Yan Li; Hong Yin; Jian Zhang
Journal:  Int J Mol Sci       Date:  2012-03-22       Impact factor: 6.208

5.  Synthesis and Cytotoxic Activity of Novel Tetrahydrocurcumin Derivatives Bearing Pyrazole Moiety.

Authors:  Ahmed Mahal; Ping Wu; Zi-Hua Jiang; Xiaoyi Wei
Journal:  Nat Prod Bioprospect       Date:  2017-11-01

6.  Design, Synthesis, and Biological Activities of Novel Pyrazole Oxime Compounds Containing a Substituted Pyridyl Moiety.

Authors:  Cuili Chen; Jia Chen; Haiying Gu; Ning Bao; Hong Dai
Journal:  Molecules       Date:  2017-05-25       Impact factor: 4.411

7.  New 3-Cyano-2-Substituted Pyridines Induce Apoptosis in MCF 7 Breast Cancer Cells.

Authors:  Ahmed Malki; Mona Mohsen; Hassan Aziz; Ola Rizk; Omima Shaban; Mohamed El-Sayed; Zaki A Sherif; Hayam Ashour
Journal:  Molecules       Date:  2016-02-18       Impact factor: 4.411

8.  Synthesis of Novel 2-Thiouracil-5-Sulfonamide Derivatives as Potent Inducers of Cell Cycle Arrest and CDK2A Inhibition Supported by Molecular Docking.

Authors:  Samar S Fatahala; Amira I Sayed; Shahenda Mahgoub; Heba Taha; Mohamed-I Kotb El-Sayed; Mohamed F El-Shehry; Samir M Awad; Rania H Abd El-Hameed
Journal:  Int J Mol Sci       Date:  2021-11-04       Impact factor: 5.923

9.  Oxime derivative TFOBO promotes cell death by modulating reactive oxygen species and regulating NADPH oxidase activity in myeloid leukemia.

Authors:  Ahyoung Jo; Jae-Hwan Kwak; Soo-Yeon Woo; Bo-Young Kim; Yonghae Son; Hee-Seon Choi; Jayoung Kim; Munju Kwon; Hyok-Rae Cho; Seong-Kug Eo; Ji Ho Nam; Hyung-Sik Kim; Ninib Baryawno; Dongjun Lee; Koanhoi Kim
Journal:  Sci Rep       Date:  2022-05-07       Impact factor: 4.996

10.  Anticancer evaluation and molecular modeling of multi-targeted kinase inhibitors based pyrido[2,3-d]pyrimidine scaffold.

Authors:  Heba S A Elzahabi; Eman S Nossier; Nagy M Khalifa; Rania A Alasfoury; May A El-Manawaty
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.